Breaking NewsNews

FDA gives full approval to Pfizer’s COVID-19 vaccine

NEWS - WWETV Administration

covid-19
The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, a milestone that could boost public confidence in the shots and spur more companies, universities and local governments to make vaccinations mandatory.

WASHINGTON — The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, a milestone that could boost public confidence in the shots and spur more companies, universities and local governments to make vaccinations mandatory.

The Pentagon immediately announced it will press ahead with plans to require members of the military to get the vaccine as the U.S., and the world, battle the extra-contagious delta variant.

The formula made by Pfizer and its German partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which has never before had so much evidence to judge a shot’s safety. More than 200 million Pfizer doses have been administered in the U.S. – and hundreds of millions more worldwide – under special emergency provisions since December.

“Vaccines are one of our greatest weapons against the virus,” acting FDA Commissioner Janet Woodcock said. “We hope this approval will bolster confidence in those who’ve been wavering.”

Pfizer said the U.S. is the first country to grant the company’s vaccine full approval. The shot will be marketed in the U.S. under the brand name Comirnaty.